Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Up 27.2% in November

Silo Pharma, Inc. (NASDAQ:SILO) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 129,600 shares, an increase of 27.2% from the October 31st total of 101,900 shares. Approximately 3.0% of the shares of the stock are short sold. Based on an average daily volume of 178,200 shares, the short-interest ratio is presently 0.7 days.

Silo Pharma Stock Up 11.1 %

NASDAQ SILO traded up $0.10 during trading hours on Friday, reaching $1.00. The company’s stock had a trading volume of 8,598,610 shares, compared to its average volume of 1,575,918. The firm’s 50-day moving average price is $1.08 and its 200-day moving average price is $1.33. Silo Pharma has a 1 year low of $0.77 and a 1 year high of $4.50.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.